Bayer AG: Bidding to Win Merck’s OTC Business Case Solution Soon after sending their finest and last deal to get Merck’s Customer Care Department, a selection of “non-prescription” (OTC) items with sales amounting to $2 billion, the Bayer M&A group was offered a possibility to modify their quote since another possible acquirer – most likely […]